Table 3.
Correlates of Adherence (scale scores entered as dichotomous variables)a
Variable | Odds Ratio | 95% CI | P Value | |
Lower Limit | Upper Limit | |||
Female | 0.752 | 0.542 | 1.044 | .089 |
Age | 0.999 | 0.985 | 1.014 | .937 |
White | 0.998 | 0.683 | 1.459 | .993 |
College graduate* | 1.652 | 1.202 | 2.270 | .002 |
Alcohol use** | 0.521 | 0.396 | 0.686 | < .001 |
Body mass index | 1.001 | 0.985 | 1.017 | .922 |
Comorbid count | 1.033 | 0.930 | 1.149 | .541 |
SF-8 physical score | 0.847 | 0.631 | 1.138 | .272 |
No. of depressive episodes | 1.001 | 0.986 | 1.016 | .879 |
No. of manic episodes | 0.993 | 0.976 | 1.011 | .454 |
BASIS-24 total score** | 0.542 | 0.403 | 0.728 | < .001 |
LUNSERS | ||||
Total (excluding red herrings)** | 0.597 | 0.412 | 0.865 | .006 |
Red herrings | 1.364 | 0.951 | 1.957 | .092 |
Satisfaction With Antipsychotic Medication scale* | 2.401 | 1.817 | 3.172 | < .001 |
Second-generation antipsychotics | 1.124 | 0.836 | 1.512 | .439 |
Traditional antipsychotics | 0.414 | 0.137 | 1.247 | .117 |
Mood stabilizers | 1.188 | 0.763 | 1.849 | .447 |
Selective serotonin reuptake inhibitors | 0.953 | 0.628 | 1.448 | .823 |
Serotonin-norepinephrine reuptake inhibitors | 0.834 | 0.462 | 1.504 | .546 |
Dopamine-norepinephrine reuptake inhibitors | 1.216 | 0.711 | 2.081 | .475 |
Other antidepressants | 1.784 | 0.847 | 3.757 | .128 |
Sedative hypnotics | 0.930 | 0.522 | 1.657 | .805 |
Monotherapy use* | 1.418 | 1.025 | 1.962 | .035 |
Method: logistic regression analysis.
*Indicates a positive correlation.
** Indicates a negative correlation.
Abbreviations: BASIS-24 = 24-item Behavior and Symptom Identification Scale, LUNSERS = Liverpool University Neuroleptic Side-Effect Rating Scale, SF-8 = Medical Outcomes Study 8-item Short-Form Health Survey, WPAI = Work Productivity and Activity Impairment.